🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 2 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/11/1995 | 30,41 | 30,41 | 29,48 | 29,94 | +1,59% | 3,08% | 11.194 |
| 02/11/1995 | 30,41 | 30,41 | 29,48 | 29,48 | -3,08% | 3,08% | 10.526 |
| 01/11/1995 | 29,48 | 30,41 | 29,48 | 30,41 | +3,17% | 3,17% | 13.305 |
| 31/10/1995 | 29,48 | 30,88 | 29,48 | 29,48 | +0,00% | 4,76% | 18.809 |
| 30/10/1995 | 29,48 | 30,88 | 29,48 | 29,48 | +0,00% | 4,76% | 5.504 |
| 27/10/1995 | 31,82 | 31,82 | 29,01 | 29,48 | -5,97% | 8,82% | 49.746 |
| 26/10/1995 | 29,48 | 31,82 | 29,48 | 31,35 | +6,35% | 7,94% | 30.430 |
| 25/10/1995 | 29,94 | 31,35 | 29,48 | 29,48 | -4,55% | 6,25% | 17.873 |
| 24/10/1995 | 30,41 | 30,88 | 29,94 | 30,88 | +0,00% | 3,08% | 17.446 |
| 23/10/1995 | 30,41 | 31,35 | 29,94 | 30,88 | +0,00% | 4,62% | 22.682 |
| 20/10/1995 | 31,35 | 31,35 | 30,41 | 30,88 | -1,49% | 2,99% | 13.759 |
| 19/10/1995 | 31,35 | 31,82 | 30,41 | 31,35 | +0,75% | 4,48% | 7.561 |
| 18/10/1995 | 31,35 | 32,75 | 30,41 | 31,11 | -5,00% | 7,46% | 72.402 |
| 17/10/1995 | 31,35 | 32,75 | 31,35 | 32,75 | +0,00% | 4,48% | 8.843 |
| 16/10/1995 | 33,22 | 33,22 | 31,35 | 32,75 | +1,45% | 5,63% | 7.454 |
| 13/10/1995 | 33,22 | 33,22 | 31,82 | 32,28 | +0,00% | 4,23% | 20.331 |
| 12/10/1995 | 29,94 | 32,75 | 29,94 | 32,28 | +7,81% | 9,37% | 23.992 |
| 11/10/1995 | 30,88 | 31,35 | 29,94 | 29,94 | -1,54% | 4,55% | 55.704 |
| 10/10/1995 | 31,82 | 31,82 | 29,94 | 30,41 | -5,80% | 5,88% | 51.937 |
| 09/10/1995 | 33,69 | 33,69 | 31,35 | 32,28 | -1,43% | 6,94% | 21.347 |
| 06/10/1995 | 32,75 | 34,15 | 32,75 | 32,75 | -1,41% | 4,29% | 51.643 |
| 05/10/1995 | 35,09 | 35,09 | 32,28 | 33,22 | -5,33% | 8,00% | 37.190 |
| 04/10/1995 | 35,56 | 36,96 | 34,15 | 35,09 | -3,85% | 7,89% | 22.228 |
| 03/10/1995 | 36,49 | 36,49 | 35,56 | 36,49 | +0,00% | 2,56% | 12.824 |
| 02/10/1995 | 37,43 | 37,43 | 35,56 | 36,49 | -1,27% | 5,00% | 18.702 |
| 29/09/1995 | 37,43 | 37,90 | 35,56 | 36,96 | +0,00% | 6,25% | 64.120 |
| 28/09/1995 | 36,96 | 36,96 | 35,56 | 36,96 | +3,95% | 3,80% | 12.263 |
| 27/09/1995 | 36,96 | 36,96 | 35,56 | 35,56 | -2,56% | 3,80% | 28.266 |
| 26/09/1995 | 36,03 | 37,43 | 35,56 | 36,49 | -1,27% | 5,19% | 33.636 |
| 25/09/1995 | 37,43 | 37,43 | 36,03 | 36,96 | -1,25% | 3,75% | 14.961 |